Ryman Healthcare Ltd (“RYM”) – Trading Halt of Securities

NZX Limited
Level 2, NZX Centre
11 Cable Street
PO Box 2959
Wellington 6140
New Zealand
Tel +64 4 472 7599

www.nzx.com

Memorandum

To:
Market Participants
From:
NZX Product Operations
Date:
Monday, 24 February 2025
Subject
: Ryman Healthcare Limited (“RYM”) – Trading Halt of Securities


Message
:
NZ RegCo has approved a trading halt application from Ryman Healthcare Limited (“RYM”).
Trading in RYM equity and quoted debt securities was halted prior to market pre-open today.

Attached is the trading halt application, for further information.

Please contact NZX Product Operations on +64 4 496 2853 or productoperations@nzx.com
with any queries.

ENDS

---

24 February 2025

To: NZ RegCo
11 Cable Street
Wellington
New Zealand

issuer@nzregco.com

Request for trading halt: Ryman Healthcare Limited (NZX Codes: RYM and RYM010)
We request a trading halt to be applied to Ryman Healthcare Limited’s (Ryman) ordinary shares (ISIN:
NZRYME0001S4) and fixed rate, secured, unsubordinated bonds (ISIN: NZRYMD0010L2) under NZX
Listing Rule 9.9.1(a) and set out below details of the request as per the rules of NZX.
We would like the trading halt to commence from prior to the commencement of trading today, 24
February 2025 and being lifted at the earlier of: (i) announcement of completion of the placement and
institutional offer described below; and (ii) opening of trading on the NZX on 26 February 2025.
Reasons for trading halt:
Ryman is proposing to raise approximately NZ$1 billion of new capital by way of an approximately
NZ$313 million placement (Placement) to be conducted by Jarden Securities Limited, Craigs
Investment Partners Limited (Craigs) and Forsyth Barr Limited (together, Joint Lead Managers),
together with an approximately NZ$688 million accelerated non-renounceable entitlement offer
(ANREO). The Placement and the ANREO are to be fully underwritten by Jarden Partners Limited
(together with Jarden Securities Limited, Jarden), Craigs and Forsyth Barr Group Limited (together with
Forsyth Barr Limited, Forsyth Barr).
Ryman considers that a trading halt is desirable to enable Jarden, Craigs, Forsyth Barr and Ryman to
conduct the Placement and the institutional entitlement offer component of the ANREO and determine
the allocation of shares. Ryman considers that, but for the trading halt, the Placement and the institutional
entitlement offer component of the ANREO process would impact a fair, orderly or transparent market
as information about the Placement, the institutional offer component of the ANREO or take up by
investors may be known by some market participants and not others, so the market would not be trading
on a fully informed basis.
As soon as the Placement and institutional entitlement offer component of the ANREO and the
allocation of shares under them is completed, Ryman will be in a position to release details of the results
of the Placement and institutional entitlement offer component of the ANREO to the market. Ryman
believes that such information will be price sensitive.

How long we want the trading halt to last:
We would like the trading halt to last up to two trading days, commencing from the commencement of
trading on 24 February 2025 and being lifted at the earlier of: (i) announcement of the outcome of the
Placement and institutional entitlement offer component of the ANREO, and (ii) opening of trading on
the NZX on 26 February 2025.

The event we expect to happen that will end the trading halt:
We expect the trading halt to end once we are in a position to announce the outcome of the Placement
and institutional entitlement offer component of the ANREO. We expect this to occur on 25 February
2025 or before market open on the NZX on 26 February 2025.

Other information necessary to inform the market about the trading halt or that
NZ RegCo has requested:
We do not believe that there is any other information necessary to inform the market about the trading
halt.
We confirm that we are not aware of any reason why the trading halt should not be granted.
Yours sincerely


Morgan Powell
General Counsel